Prognostic role of immunosuppressive acidic protein in advanced ovarian cancer

American Journal of Obstetrics and Gynecology

Volumn 175, Issue 6, 1996, Pages 1606-1610

  Scambia, G ^a   Foti, E ^a   Ferrrandina, G ^a   Leone, F P ^a   Gadducci, A ^a   Benedetti Panici, P ^a   Mancuso, S ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Immunosuppressive acidic protein; ovarian cancer prognosis; serum levels

Indexed keywords

IMMUNOSUPPRESSIVE ACID PROTEIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CELL PROLIFERATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL;

EID: 0030460861     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(96)70113-8     Document Type: Article

References (24)

1. Annual report on the results of treatment in gynecological cancer-1991 Int J Gynecol Obstet 36 1991 258 268
2. K Tamura Y Shibata Y Matsuda N. Ishida Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of ovarian cancer patients Cancer Res 41 1981 3244 3252
3. KM Chiu RF Mortensen AP Osmand H. Gewurtz Interactions of alpha-1 acidic glycoprotein with the immune system Immunology 32 1977 997 1005
4. K Yamashita H Hayashi K Mura M Ishikawa T. Shimizu Serum immunosuppressive substance in patients with gynecologic cancer Cancer 57 1986 69 74
5. N Shimizu M Yamashiro A Morakami R Hamazoe M. Maeta Diagnostic accuracy of combination of assays for immunosuppressive acidic protein and carcinoembryonic antigen in detection of recurrence of gastric cancer Eur J Cancer 27 1991 190 193
6. N Yamanaka Y Harabuchi T Himi A. Kataura Immunosuppressive substance in the sera of head and neck cancer Cancer 54 1984 652 656
7. M Sawada Y Okudaira Y Matsui Y. Shimizu Immunosuppressive acidic protein in patients with ovarian cancer Cancer 52 1983 2081 2085
8. M Castelli F Battaglia G Scambia Immunosuppressive acidic protein and CA 125 levels in patients with ovarian cancer Oncology 48 1991 13 17
9. T Igarashi S Murakami S Isaka T Okano J Shimazaki O. Matsuzaki Serum immunosuppressive acidic protein as a tumor marker for renal cell carcinoma Eur Urol 19 1991 332 335
10. J Sakamoto A Koike S Saji S Teramukai Y Ohashi H. Nakazato Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier Surg Today 22 1992 530 536
11. F Battaglia G Scambia P Benedetti Panici Immunosuppressive acidic protein (IAP) and squamous cell carcinoma antigen (SCC) in patients with cervical cancer Gynecol Oncol 53 1994 176 182
12. P Benedetti Panici S Greggi G Scambia Efficacy and toxicity of very high-dose cisplatin in advanced ovarian carcinoma: 4-year survival analysis and neurological follow-up Int J Gynecol Cancer 3 1993 44 53
13. WF Sample HR Gertner PB. Chretien Inhibition of phytohemogglutinin-induced in vitro lymphocyte transformation by serum from patients with carcinoma J Natl Cancer Inst 46 1971 1291 1297
14. Y Shibata K Tamura N. Ishida In vivo analysis of the suppressive effects of immunosuppressive acidic protein, a type of alpha-1 acid protein, in connection with its high level in tumor-bearing mice Cancer Res 43 1983 2889 2896
15. R Simon DG. Altman Statistical aspects of prognostic factor studies in oncology Br J Cancer 69 1994 979 985
16. K Pummer P Purstner HL Auher Serum immunosuppressive acid protein predict lymphnode metastates in patients with renal cell carcinoma Br J Urol 73 1994 612 614
17. A Mantovani B Bottazzi F Colotta S Sozzani L. Ruco The origin and function of tumor-associated macrophages Immunol Today 7 1992 265 270
18. BM Kacinski RS Bloodgood PE Schrwarts D Carter ER. Stanley Macrophage colony-stimulating factor produced by human ovarian and endometrial adenocarcinoma-derived cell lines is present at abnormally high levels in the plasma of ovarian carcinoma patients with active disease Cancer Cells 7 1989 333 337
19. BM. Kacinski CSF-1 and its receptor in ovarian, endometrial and breast cancer Ann Med 27 1995 79 85
20. I Tamm I Cardinale J Krueger JS Murphy LT May PB. Seghall Interleukin-6 decreases cell-cell association and increases motility of ductal breast carcinoma cells J Exp Med 170 1989 1649 1669
21. J Tanner G. Tosato Impairment of natural killer functions by interleukin-6 increases lymphoblastoid cell tumorigenicity in athimic mice J Clin Invest 88 1992 239 247
22. JM Watson JL Sensitaffar JS Berek O. Martinez-Maza Constitutive production of interleukin-6 by ovarian cancer cell lines and by primary ovarian tumor cultures Cancer Res 50 1990 6959 6965
23. JS Berek CBS Chung KBS Kaldi JM Watson RM Knox O. Martinez-Maza Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer Am J Obstet Gynecol 164 1991 1038 1043
24. G Scambia U Testa P Benedetti Panici Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer Br J Cancer 71 1995 354 356